PV-DPD-19
PV-DPD-19 is an autoinducer-2 (AI-2) quorum sensing inhibitor. PV-DPD-19 reduces AI-2 production and inhibits the expression of multiple MSCRAMMs. In co-culture systems with Staphylococcus aureus, PV-DPD-19 decreases the production of pyocyanin and Elastase in Pseudomonas aeruginosa. PV-DPD-19 impairs the adhesion ability of Staphylococcus aureus to lung epithelial cells. PV-DPD-19 inhibits biofilm formation of Pseudomonas aeruginosa (MBIC50 = 27 μg/mL) and Staphylococcus aureus (MBIC50 = 35 μg/mL). PV-DPD-19 shows no cytotoxicity in both in vitro lung epithelial cell models and in vivo Galleria mellonella larva models.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3112321-20-4
- Formule: C15H19NO5
- Masse moléculaire:293.32
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
PV-DPD-19 inhibits biofilm formation by *Pseudomonas aeruginosa* (MBIC50 = 27 μg/mL) and *Staphylococcus aureus* (MBIC50 = 35 μg/mL)[1].
PV-DPD-19 significantly reduces the adhesion rate of *Staphylococcus aureus* to human A549 epithelial cells by approximately 30%[1].
PV-DPD-19 (2 mM; overnight, 8 h) significantly reduces AI-2 production in *Staphylococcus aureus* SH1000 as determined by the *Vibrio harveyi* bioluminescence assay[1].
PV-DPD-19 (20-40 μM; 16 h) reduces pyocyanin production in *Pseudomonas aeruginosa* PAO1 in a dose-dependent manner[1].
PV-DPD-19 (3.12-200 μM; 24 h) shows no cytotoxicity against epithelial cell line A549[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human alveolar basal epithelial carcinoma A549 cells
-
Concentration:3.12-200 μM
-
Incubation Time:24 h
-
Result:Maintained cell viability at 100% for all compounds.
Showed no statistically significant reduction in viability.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:larvae (0.2-0.3 g in weight)[1]
-
Dosage:1 μM; 100 μM; 200 μM
-
Administration:injected into the proleg using a microsyringe; single dose
-
Result:Observed 100% survival at 24 hours post-injection for all doses.
Observed 100% survival at 48 hours post-injection for 1 μM and 200 μM doses, and 97% survival for 100 μM dose.
Observed 98% survival at 72 hours post-injection for 1 μM and 200 μM doses, and 97% survival for 100 μM dose.
Showed no significant survival difference compared to untreated controls.
Chemical Information
-
CAS No. 3112321-20-4
-
Masse moléculaire 293.32
-
Formule C15H19NO5
-
SMILES
CC1(C)OC(C(N[C@@H](CC2=CC=CC=C2)C(O)=O)=O)CO1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
PV-DPD-19 Related Classifications
HY-182942 Related Classifications
Powered by Bioz